Literature DB >> 15495051

Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with learning disabilities.

A Hassiotis1, I Hall.   

Abstract

BACKGROUND: Outwardly directed aggressive behaviour is a significant part of problem behaviours presented by people with learning disabilities. Prevalence rates between 3.3% to 36% have been reported in the literature. Such behaviours run a long term course and are a major cause of social exclusion
OBJECTIVES: To determine the efficacy of behavioural and cognitive behavioural interventions for outwardly-directed aggressive behaviour for people with learning disabilities. SEARCH STRATEGY: The Cochrane Library (CENTRAL), MEDLINE, EMBASE, CINAHL, ERIC and PsycINFO were searched using a strategy combining (Learning or synonyms) and (Disabilities or synonyms) and (Behaviour or synonyms) and (treatment or synonyms) to late 2002. Where appropriate, research filters were used. SELECTION CRITERIA: Studies were selected if more than 4 participants, children or adults, were allocated by random or quasi-random methods to either intervention or standard treatment/wait list. DATA COLLECTION AND ANALYSIS: References identified by electronic searches, examinations of bibliography and personal contacts were screened against inclusion criteria by two independent reviewers. MAIN
RESULTS: Three studies based on adult populations with learning disabilities were deemed to be suitable for inclusion but data were only available in a form suitable for meta-analysis in two studies. Direct interventions based on cognitive-behavioural methods (modified relaxation, assertiveness training with problem solving, and anger management) appear to have some impact on reduction of aggressive behaviour at the end of treatment but not at follow up (up to six months) as rated by individuals and their carers. REVIEWERS'
CONCLUSIONS: The existing evidence on the efficacy of cognitive behavioural and behavioural interventions on outwards directed aggression in children and adults with ID is scant. There is a paucity of methodologically sound clinical trials. Given the impact of such behaviours on the affected individual, his or her carers and on service providers, effective interventions are essential. It is also important to investigate cost efficacy of treatment models against existing treatments. We recommend that randomised controlled trials of sufficient power are carried out using primary outcomes of reduction in outward directed aggression, improvement in quality of life and cost efficacy as measured by standardised scales.

Entities:  

Mesh:

Year:  2004        PMID: 15495051     DOI: 10.1002/14651858.CD003406.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  4 in total

Review 1.  Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with intellectual disabilities.

Authors:  Afia Ali; Ian Hall; Jessica Blickwedel; Angela Hassiotis
Journal:  Cochrane Database Syst Rev       Date:  2015-04-07

Review 2.  Aggressive behaviour in adults with intellectual disability: defining the role of drug treatment.

Authors:  Patricia Oliver-Africano; Declan Murphy; Peter Tyrer
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

3.  Cognitive behaviour therapy (CBT) for anxiety and depression in adults with mild intellectual disabilities (ID): a pilot randomised controlled trial.

Authors:  Angela Hassiotis; Marc Serfaty; Kiran Azam; Andre Strydom; Sue Martin; Charles Parkes; Robert Blizard; Michael King
Journal:  Trials       Date:  2011-04-14       Impact factor: 2.279

Review 4.  A systematic review and synthesis of outcome domains for use within forensic services for people with intellectual disabilities.

Authors:  Catrin Morrissey; Peter E Langdon; Nicole Geach; Verity Chester; Michael Ferriter; William R Lindsay; Jane McCarthy; John Devapriam; Dawn-Marie Walker; Conor Duggan; Regi Alexander
Journal:  BJPsych Open       Date:  2017-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.